Clinical Trial Results:
Extensión de 28 semanas de duración del estudio multicéntrico, doble ciego, aleatorizado, de grupos paralelos que compara el efecto de 24 semanas de tratamiento con 50 mg bid de LAF237 frente a placebo como terapia añadida en pacientes con Diabetes Tipo 2 tratados con insulina
Summary
|
|
EudraCT number |
2004-001979-18 |
Trial protocol |
ES |
Global completion date |
10 Apr 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Mar 2017
|
First version publication date |
03 Mar 2017
|
Other versions |
|
Summary report(s) |
CLAF237A2311E1 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.